KINETA, INC./DE (KA)
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Mercer Island, WA.
Address
7683 SE 27TH STREET
MERCER ISLAND, WA 98040
Founded
2008
Number of Employees
11
Website
http://www.kinetabio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)